Depression Treatment Optimization
Sharpen your ability to select, optimize, and adjust antidepressant regimens, including strategies for cases that don't respond to first-line treatment.
What this track covers
This track covers the full arc of depression management: screening and severity assessment, first-line agent selection based on patient-specific factors, dose optimization and switching strategies, and approaches to treatment-resistant depression including augmentation. It's built for clinicians who already prescribe or co-manage antidepressants and want a structured way to sharpen decision-making across common and difficult cases.
What you will practice
- Interpreting PHQ-9 and other severity scores to guide next steps
- Choosing among first-line antidepressant classes based on comorbidities and side-effect profile
- Deciding when to optimize dose versus switch agents versus augment
- Recognizing patterns that suggest treatment-resistant depression
- Applying measurement-based care to track response over time
Simulator scenario
A patient with persistent depressive symptoms after an adequate trial of a first-line agent, requiring the clinician to decide between optimizing, switching, or augmenting.
Board question topics
- Differentiating adequate trial from inadequate dosing or duration
- Augmentation strategy selection in partial responders
- Recognizing red flags requiring specialist referral
- Applying measurement-based care tools in follow-up visits
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free